Euda Health Holdings Ltd. Announces Conversion of Shares and Debt Repayment Agreement with Indigo Capital
Euda Health Holdings Ltd. has announced a new debt conversion agreement with Indigo Capital LP. As part of this agreement, Euda Health will convert a portion of its debt into equity by issuing 41,620 shares to Indigo Capital, following a conversion notice dated September 15, 2025. Additionally, the company has committed to paying off the remaining balance of the promissory note by December 15, 2025. In return, Indigo Capital has agreed not to make further conversions of the note until mid-December, unless Euda Health's stock price remains at or above $2.00 for three consecutive trading days. Both parties have agreed to waive any previous breaches of the agreement, maintaining the original terms otherwise unchanged.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Euda Health Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-014384), on September 22, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.